GSK Records $400M Legal Charge In Off-Label Probe
GSK has disclosed in several annual reports that the U.S. attorney's office in Colorado is investigating how the company has promoted nine of its highest-selling pharmaceuticals from 1997 through 2004, when the inquiry was launched.
The authorities are looking particularly at whether the company was promoting the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login